Acceptance and Commitment Therapy for Bipolar Disorder
ACT for Syndromic and Subsyndromic Depression in Bipolar Disorder
Recruiting
N/AInterventional Study
Bipolar Disorder
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 – 65
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
42 (estimated)
Sponsor
Beny Lafer · Other
Who this trial is looking for
This trial is looking for people with Bipolar Disorder who have depressive symptoms. Participants will receive therapy sessions designed to improve their mood and quality of life while they continue their regular medication.
Are You a Good Fit for This Trial?
You may be able to join if
I have been diagnosed with Bipolar Disorder type I or II.
I have depressive symptoms.
I am not currently undergoing psychotherapy.
I can attend in-person group therapy sessions.
I am willing to sign a consent form.
You may not be able to join if
I have an organic mental disorder.
I have manic or hypomanic symptoms.
I am currently undergoing psychotherapy.
I have had a major medication change in the last 30 days.
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
The goal of this clinical trial is to test the efficacy of Acceptance and Commitment Therapy (ACT) as a psychotherapeutic treatment for patients with Bipolar Disorder (BD). The following questions will be investigated:
* The efficacy of ACT in reducing depressive symptoms in patients with BD.
* The efficacy of ACT in improving the quality of life in patients with BD.
* The efficacy of ACT in impr…
The goal of this clinical trial is to test the efficacy of Acceptance and Commitment Therapy (ACT) as a psychotherapeutic treatment for patients with Bipolar Disorder (BD). The following questions will be investigated:
* The efficacy of ACT in reducing depressive symptoms in patients with BD.
* The efficacy of ACT in improving the quality of life in patients with BD.
* The efficacy of ACT in improving functionality in patients with BD.
* The efficacy of ACT in improving sleep quality in patients with BD.
* The efficacy of ACT in improving psychological flexibility in patients with BD
Participants in the clinical group will undergo 12, 2 hours, weekly sessions of Acceptance and Commitment Therapy, in addition to their regular pharmacological treatment.
Participants in the control group will undergo 3, 2 hours, weekly sessions of Bipolar Disorder Psychoeducation Therapy, in addition to their regular pharmacological treatment.
Scales and assessments will be used to measure study outcomes on 5 different time-points: pre-intervention (month 0), post-intervention (month 3), follow-up 1 (month 6), follow-up 2 (month 9), follow-up 3 (month 12). Mood scales will be assessed every 2 weeks for the duration of treatment and every 4 weeks during the additional 12 week follow-up period.
Results will be compared among both groups to assess the effectiveness of Acceptance and Commitment Therapy as an intervention for syndromic and sub-syndromic depression in bipolar disorder.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of Bipolar Disorder type I and II according to DSM V
* Presence of depressive symptoms (MADRS\>12)
* Not undergoing psychotherapy
* Availability to attend in-person group therapy sessions
* Signing consent form
Exclusion Criteria:
* Organic mental disorder
* Presen…
Inclusion Criteria:
* Diagnosis of Bipolar Disorder type I and II according to DSM V
* Presence of depressive symptoms (MADRS\>12)
* Not undergoing psychotherapy
* Availability to attend in-person group therapy sessions
* Signing consent form
Exclusion Criteria:
* Organic mental disorder
* Presence of manic or hypomanic symptoms (YMRS\>12)
* Currently undergoing psychotherapy (not able to pause during the study)
* Major medication change in last 30 days
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.